K2 HealthVentures Provides $35MM Credit Facility to Alto Neuroscience
Alto Neuroscience completed a $25 million equity investment by new investor, Alpha Wave Ventures. In addition, Alto entered into a credit facility with K2 HealthVentures for up to $35 million, allowing access to additional capital and flexibility as the company advances its clinical-stage pipeline.
January 31, 2023
Alpha Wave Global | Alto Neuroscience | Chris Dimitropoulos | K2 HealthVentures | Nick Smith | Parag Shah
Ian Koplin